BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34247495)

  • 1. Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study.
    Patel AP; Wang M; Kartoun U; Ng K; Khera AV
    Circulation; 2021 Aug; 144(6):410-422. PubMed ID: 34247495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in the risk of cardiovascular disease across ethnic groups: UK Biobank observational study.
    Razieh C; Zaccardi F; Miksza J; Davies MJ; Hansell AL; Khunti K; Yates T
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2594-2602. PubMed ID: 36064688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.
    Haque W; Grandhi GR; Kanaya AM; Kandula NR; Nasir K; Al Rifai M; Uddin SMI; Fedeli U; Sattar N; Blumenthal RS; Blaha MJ; Cainzos-Achirica M
    Atherosclerosis; 2021 Oct; 334():48-56. PubMed ID: 34481175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lp(a) (Lipoprotein[a]) Concentrations and Incident Atherosclerotic Cardiovascular Disease: New Insights From a Large National Biobank.
    Patel AP; Wang (汪敏先) M; Pirruccello JP; Ellinor PT; Ng K; Kathiresan S; Khera AV
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):465-474. PubMed ID: 33115266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.
    Said MA; Verweij N; van der Harst P
    JAMA Cardiol; 2018 Aug; 3(8):693-702. PubMed ID: 29955826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent Revisited) -- a prospective population-based study.
    Tillin T; Hughes AD; Mayet J; Whincup P; Sattar N; Forouhi NG; McKeigue PM; Chaturvedi N
    J Am Coll Cardiol; 2013 Apr; 61(17):1777-86. PubMed ID: 23500273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.
    Kandula NR; Kanaya AM; Liu K; Lee JY; Herrington D; Hulley SB; Persell SD; Lloyd-Jones DM; Huffman MD
    J Am Heart Assoc; 2014 Oct; 3(5):e001117. PubMed ID: 25277669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of type 2 diabetes to all-cause mortality, cardiovascular disease incidence and cancer incidence in white Europeans and South Asians: findings from the UK Biobank population-based cohort study.
    Muilwijk M; Ho F; Waddell H; Sillars A; Welsh P; Iliodromiti S; Brown R; Ferguson L; Stronks K; van Valkengoed I; Pell JP; Gray SR; Gill JMR; Sattar N; Celis-Morales C
    BMJ Open Diabetes Res Care; 2019; 7(1):e000765. PubMed ID: 31908795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Diabetes and Atherosclerotic Cardiovascular Disease Among Asian American Adults: Implications, Management, and Future Directions: A Scientific Statement From the American Heart Association.
    Kwan TW; Wong SS; Hong Y; Kanaya AM; Khan SS; Hayman LL; Shah SH; Welty FK; Deedwania PC; Khaliq A; Palaniappan LP;
    Circulation; 2023 Jul; 148(1):74-94. PubMed ID: 37154053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences in cardiac structure and function assessed by MRI in healthy South Asian and White European people: A UK Biobank Study.
    Parke KS; Brady EM; Alfuhied A; Motiwale RS; Razieh CS; Singh A; Arnold JR; Graham-Brown MPM; Bilak JM; Ayton SL; Dattani A; Yeo JL; McCann GP; Gulsin GS
    J Cardiovasc Magn Reson; 2024 Summer; 26(1):100001. PubMed ID: 38218434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease.
    Trinder M; Uddin MM; Finneran P; Aragam KG; Natarajan P
    JAMA Cardiol; 2020 Oct; 6(3):1-9. PubMed ID: 33021622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Letter by Enas and Varkey Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
    Enas EA; Varkey B
    Circulation; 2022 Feb; 145(5):e146. PubMed ID: 35100018
    [No Abstract]   [Full Text] [Related]  

  • 13. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
    Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
    Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response by Patel and Khera to Letter Regarding Article, "Quantifying and Understanding the Higher Risk of Atherosclerotic Cardiovascular Disease Among South Asian Individuals: Results From the UK Biobank Prospective Cohort Study".
    Patel AP; Khera AV
    Circulation; 2022 Feb; 145(5):e147-e148. PubMed ID: 35100017
    [No Abstract]   [Full Text] [Related]  

  • 15. Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank.
    Tseng RMWW; Rim TH; Shantsila E; Yi JK; Park S; Kim SS; Lee CJ; Thakur S; Nusinovici S; Peng Q; Kim H; Lee G; Yu M; Tham YC; Bakhai A; Leeson P; Lip GYH; Wong TY; Cheng CY
    BMC Med; 2023 Jan; 21(1):28. PubMed ID: 36691041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.
    Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV
    JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Mitochondrial DNA Copy Number With Cardiovascular Disease.
    Ashar FN; Zhang Y; Longchamps RJ; Lane J; Moes A; Grove ML; Mychaleckyj JC; Taylor KD; Coresh J; Rotter JI; Boerwinkle E; Pankratz N; Guallar E; Arking DE
    JAMA Cardiol; 2017 Nov; 2(11):1247-1255. PubMed ID: 29049454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actionable absolute risk prediction of atherosclerotic cardiovascular disease based on the UK Biobank.
    Kesar A; Baluch A; Barber O; Hoffmann H; Jovanovic M; Renz D; Stopak BL; Wicks P; Gilbert S
    PLoS One; 2022; 17(2):e0263940. PubMed ID: 35148360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and Ancestries.
    Weale ME; Riveros-Mckay F; Selzam S; Seth P; Moore R; Tarran WA; Gradovich E; Giner-Delgado C; Palmer D; Wells D; Saffari A; Sivley RM; Lachapelle AS; Wand H; Clarke SL; Knowles JW; O'Sullivan JW; Ashley EA; McVean G; Plagnol V; Donnelly P
    Am J Cardiol; 2021 Jun; 148():157-164. PubMed ID: 33675770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Life satisfaction and the risk of atherosclerotic cardiovascular disease in the general Japanese population: the Suita Study.
    Arafa A; Kashima R; Kokubo Y
    Environ Health Prev Med; 2023; 28():62. PubMed ID: 37899209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.